Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

DiaPep 277

Generic Name: DiaPep 277

Drug Type: Small Molecule

Chemical Formula: C_₁₀₆H_₁₈₀N_₂₈O_₃₄

CAS Number: 179822-83-4

Unique Ingredient Identifier: F8778UWB0A

Overview

DiaPep 277 is a 24-mer laboratory-made peptide derived from Hsp60(437-460).

Background

DiaPep 277 is a 24-mer laboratory-made peptide derived from Hsp60(437-460).

Indication

Investigated for use/treatment in diabetes mellitus type 1, autoimmune diseases, and diabetes mellitus type 2.

Associated Conditions

No associated conditions information available.

Clinical Trials

Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®

Phase 3

Terminated

Posted: 2013/07/12

Sponsor:Andromeda Biotech Lt...

ID:NCT01898286

The Safety and Efficacy of Administrating DiaPep277® Vaccination in Type 1 Diabetes Patients.

Phase 1

Withdrawn

Posted: 2013/06/20

Sponsor:Hadassah Medical Org...

ID:NCT01881958

OPen Label Study to Evaluate Long Term Treatment Effect of DiaPep277

Phase 3

Terminated

Posted: 2011/10/26

Sponsor:Rabin Medical Center

ID:NCT01460251

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Phase 3

Completed

Posted: 2010/04/14

Sponsor:Andromeda Biotech Lt...

ID:NCT01103284

Long-Term Treatment Effect of DiaPep277 in Type 1 Diabetes

Phase 3

Completed

Posted: 2008/03/26

Sponsor:Andromeda Biotech Lt...

ID:NCT00644501

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy